Congenital Aneuploidy in Klinefelter Syndrome with B-Cell Acute Lymphoblastic Leukemia Might Be Associated with Chromosomal Instability and Reduced Telomere Length
Overview
Authors
Affiliations
Rare congenital aneuploid conditions such as trisomy 13, trisomy 18, trisomy 21 and Klinefelter syndrome (KS, 47,XXY) are associated with higher susceptibility to developing cancer compared with euploid genomes. Aneuploidy frequently co-exists with chromosomal instability, which can be viewed as a "vicious cycle" where aneuploidy potentiates chromosomal instability, leading to further karyotype diversity, and in turn, paving the adaptive evolution of cancer. However, the relationship between congenital aneuploidy and tumor initiation and/or progression is not well understood. We used G-banding analysis, array comparative genomic hybridization analysis and quantitative fluorescence in situ hybridization for telomere length analysis to characterize the leukemic blasts of a three-year-old boy with KS and B-cell acute lymphoblastic leukemia (B-ALL), to gain insight into genomic evolution mechanisms in congenital aneuploidy and leukemic development. We found chromosomal instability and a significant reduction in telomere length in leukemic blasts when compared with the non-leukemic aneuploid cells. Reviewing published cases with KS and B-ALL revealed 20 additional cases with B-ALL diagnostic cytogenetics. Including our present case, 67.7% (14/21) had acquired two or more additional chromosomal aberrations at B-ALL diagnosis. The presented data indicate that congenital aneuploidy in B-ALL might be associated with chromosomal instability, which may be fueled by enhanced telomere attrition.
Singh A, Bhardwaj P, Laux P, Pradeep P, Busse M, Luch A Front Toxicol. 2024; 6:1461587.
PMID: 39659701 PMC: 11628524. DOI: 10.3389/ftox.2024.1461587.
Telomere Dysfunction in Pediatric Patients with Differences/Disorders of Sexual Development.
Younoussa H, Gadji M, Soumboundou M, Colicchio B, Said A, Ndoye N Biomedicines. 2024; 12(3).
PMID: 38540177 PMC: 10968223. DOI: 10.3390/biomedicines12030565.
The prognostic value and mechanisms of centromere protein M in patients with lung adenocarcinoma.
Qi N, Niu Y, Li Z, Xiao L, Tang D, Gao W Transl Cancer Res. 2022; 11(10):3471-3490.
PMID: 36388055 PMC: 9641099. DOI: 10.21037/tcr-22-491.
van den Bosch T, Derks S, Miedema D Cancers (Basel). 2022; 14(20).
PMID: 36291770 PMC: 9600040. DOI: 10.3390/cancers14204986.